Early-Phase Adverse Effects and Management of Liposomal Amikacin Inhalation for Refractory Mycobacterium avium Complex Lung Disease in Real-World Settings

Atsuho Morita,1 Ho Namkoong,2 Kazuma Yagi,1 Takanori Asakura,1 Makoto Hosoya,3 Hiromu Tanaka,1 Ho Lee,1 Takunori Ogawa,1 Tatsuya Kusumoto,1 Shuhei Azekawa,1 Kensuke Nakagawara,1 Hirofumi Kamata,1 Makoto Ishii,1 Koichi Fukunaga,1 Hiroyuki Ozawa,3 Naoki Hasegawa2 1Division of Pulmonary Medicine, Depar...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Morita A, Namkoong H, Yagi K, Asakura T, Hosoya M, Tanaka H, Lee H, Ogawa T, Kusumoto T, Azekawa S, Nakagawara K, Kamata H, Ishii M, Fukunaga K, Ozawa H, Hasegawa N
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Dove Medical Press 2022-07-01
Reeks:	Infection and Drug Resistance
Onderwerpen:	mycobacterium avium complex mac nontuberculous mycobacteria ntm amikacin liposome inhalation suspension alis
Online toegang:	https://www.dovepress.com/early-phase-adverse-effects-and-management-of-liposomal-amikacin-inhal-peer-reviewed-fulltext-article-IDR
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!